<!DOCTYPE html>
<html>
<head>
<title>MaxLinear, Inc. Quarterly report pursuant to Section 13 or 15(d)</title>
<link href="https://investors.maxlinear.com/stylesheets/ir.stockpr.css" rel="stylesheet" type="text/css">
<script type="text/javascript" src="https://investors.maxlinear.com/javascripts/ir.js"></script>
<link rel="stylesheet" type="text/css" href="https://ir.stockpr.com/stylesheets/xbrl.css">
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.min.js"></script>
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.js"></script>
</head>
<body>
<style>
body {
font-family: Arial, Helvetica, sans-serif;
font-size: 12px;
color: #454545;
}
</style>
<div class="xbrl-content">
    <h3>Quarterly report pursuant to Section 13 or 15(d)</h3>
    <div id="xbrl-menu-top">
        <div class="navigation">
            <ul class="xbrl-sf-menu">
                
                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1157">Cover</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1157">Document and Entity Information</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1158">Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1158">Consolidated Balance Sheet</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1159">Consolidated Balance Sheet (Parenthetical)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1160">Consolidated Statement of Operations</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1161">Consolidated Statement of Comprehensive Income</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1162">Consolidated Statement of Comprehensive Income (Parenthetical)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1163">Consolidated Statement of Cash Flows</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item current" href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1164">Notes to Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1164">Organization and Summary of Significant Accounting Policies</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1165">Net Income (Loss) Per Share</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1166">Business Combinations</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1167">Restructuring Activity</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1168">Goodwill and Intangible Assets</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1169">Financial Instruments</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1170">Balance Sheet Details</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1171">Debt</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1172">Stock-Based Compensation</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1173">Income Taxes</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1174">Concentration of Credit Risk, Significant Customers and Geographic Information</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1175">Commitments and Contingencies</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1176">Subsequent Event</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1177">Accounting Policies</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1177">Organization and Summary of Significant Accounting Policies (Policies)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1178">Notes Tables</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1178">Net Income (Loss) Per Share (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1179">Business Combinations Business Combinations (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1180">Restructuring Activity (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1181">Goodwill and Intangibles Assets (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1182">Financial Instruments (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1183">Balance Sheet Details (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1184">Debt (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1185">Stock-Based Compensation and Employee Benefit Plans (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1186">Significant Customer and Geographic Information (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1187">Commitments and Contingencies (Tables)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1188">Notes Details</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1188">Organization and Summary of Significant Accounting Policies (Details Textuals)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1189">Net Income (Loss) Per Share (Details 1)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1190">Net Income (Loss) Per Share (Details Textuals)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1191">Business Combinations Business Combination - Exar (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1192">Business Combinations (Details Textuals)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1193">Business Combinations Business Combination - G.hn Business of Marvell (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1194">Business Combinations Pro-Forma (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1195">Restructuring Activity (Details 1)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1196">Restructuring Activity (Details 2)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1197">Restructuring Activities (Details Textuals)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1198">Goodwill and Intangibles Assets (Details 1)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1199">Goodwill and Intangibles Assets (Details 2)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1200">Goodwill and Intangibles Assets (Details 3)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1201">Goodwill and Intangibles Assets (Details 4)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1202">Goodwill and Intangibles Assets (Details 5)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1203">Goodwill and Intangibles Assets (Details Textuals)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1204">Financial Instruments (Details 1)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1205">Financial Instruments (Details 2)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1206">Financial Instruments (Details 3)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1207">Financial Instruments - Additional Information (Details Textuals)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1208">Balance Sheet Details - Cash and Investments (Details 1)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1209">Balance Sheet Details - Inventory (Details 2)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1210">Balance Sheet Details - Property and Equipment (Details 3)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1211">Balance Sheet Details - Deferred Revenue and Deferred Profit (Details 4)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1212">Balance Sheet Details- Accrued Price Protection Liability (Details 5)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1213">Balance Sheet Details - Accrued Expenses (Details 6)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1214">Debt (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1215">Stock-Based Compensation and Employee Benefit Plans - Expense by Type (Details 1)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1216">Stock-Based Compensation and Employee Benefit Plans - Awards (Details 2)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1217">Stock-Based Compensation and Employee Benefit Plans - ESPP (Details 3)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1218">Stock-Based Compensation and Employee Benefit Plans - Stock Options (Details 4)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1219">Stock-Based Compensation and Employee Benefit Plans - Additional Information (Details Textuals)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1220">Income Taxes - Additional Information (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1221">Significant Customer and Geographic Information (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1222">Commitments and Contingencies (Details 1)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1223">Commitments and Contingencies - Leases (Details 2)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1224">Commitments and Contingencies - Litigation (Details 3)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1225">Commitments and Contingencies Other (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1226">Subsequent Events (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/1227">Restricted Cash (Details)</a></li>
                                                    </ul>
                    </li>
                            </ul>
        </div>
    </div>
    <div class="spr-xbrl-document">
        <h4>Stock-Based Compensation</h4>
                <div style="clear:both;"></div>
    </div>
</div>
</body>
</html>